Contact

All Stories

  1. Pediatric kidney replacement therapies in low-to-middle income countries: a review and white paper

    Article • Pediatric Nephrology, May 2025, Springer Science + Business Media

    Dr. Rezan Topaloglu

  2. Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices

    Article • Pediatric Rheumatology, March 2025, Springer Science + Business Media

    Dr. Rezan Topaloglu

  3. Comprehensive analysis of pediatric urolithiasis in a tertiary care center and insights into demographics, risk factors, and management outcomes

    Article • Journal of Pediatric Urology, March 2025, Elsevier

    Dr. Rezan Topaloglu

  4. Achievements, priorities and strategies in pediatric nephrology in Europe: need for unifying approaches or acceptance of differences?

    Article • Frontiers in Pediatrics, December 2024, Frontiers

    Dr. Rezan Topaloglu

  5. Publisher Correction: Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey

    Article • Pediatric Nephrology, December 2024, Springer Science + Business Media

    Dr. Rezan Topaloglu

  6. Plasmapheresis for the treatment of IgA vasculitis nephritis in children: A case series

    Article • Acta Paediatrica, December 2024, Wiley

    Dr. Rezan Topaloglu

  7. Diagnosis, management and treatment of the Alport syndrome – 2024 guideline on behalf of ERKNet, ERA and ESPN

    Article • Nephrology Dialysis Transplantation, December 2024, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  8. Cystinosis metabolic bone disease: inflammatory profile in human peripheral blood mononuclear cells and derived osteoclasts

    Article • European Journal of Pediatrics, November 2024, Springer Science + Business Media

    Dr. Rezan Topaloglu

  9. Short Bowel Syndrome Is Not a Contraindication for Kidney Transplantation

    Article • Pediatric Transplantation, November 2024, Wiley

    Dr. Rezan Topaloglu

  10. Application of the updated International IgA Nephropathy Prediction Tool in children one or two years post-biopsy

    Article • Kidney International, November 2024, Elsevier

    Dr. Rezan Topaloglu

  11. Incidence, risk factors, management strategies, and outcomes of antibody-mediated rejection in pediatric kidney transplant recipients—a multicenter analysis of the Cooperative European Paediatric Renal Transplant Initiative (CERTAIN)

    Article • Pediatric Nephrology, September 2024, Springer Science + Business Media

    Dr. Rezan Topaloglu

  12. Variable phenotype and genotype of pediatric patients with HNF1B nephropathy

    Article • Clinical Nephrology, August 2024, Dustri-Verlgag Dr. Karl Feistle

    Dr. Rezan Topaloglu

  13. Favorable Outcome After Single-kidney Transplantation From Small Donors in Children: A Match-controlled CERTAIN Registry Study

    Article • Transplantation, July 2024, Wolters Kluwer Health

    Dr. Rezan Topaloglu

  14. Calcineurin inhibitor‐related hyperkalemia is caused by hyporeninemic hypoaldosteronism and fludrocortisone is an effective treatment: Report of a case series and review of the literature

    Article • Pediatric Transplantation, May 2024, Wiley

    Dr. Rezan Topaloglu

  15. Adolescence-onset atypical hemolytic uremic syndrome: is it different from infant-onset?

    Article • Clinical and Experimental Nephrology, May 2024, Springer Science + Business Media

    Dr. Rezan Topaloglu

  16. Addressing the psychosocial aspects of transition to adult care in patients with cystinosis

    Article • Pediatric Nephrology, March 2024, Springer Science + Business Media

    Dr. Rezan Topaloglu

  17. Extrarenal complications of cystinosis

    Article • Pediatric Nephrology, December 2023, Springer Science + Business Media

    Dr. Rezan Topaloglu

  18. Nefrotik Düzey Proteinüri ile Başvurunun Çocukluk Çağı Iga Vasküliti Nefriti Seyrine Etkileri

    Article • OSMANGAZİ JOURNAL OF MEDICINE, July 2023, Osmangazi Journal of Medicine

    Dr. Rezan Topaloglu

  19. Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey

    Article • Pediatric Nephrology, April 2023, Springer Science + Business Media

    Dr. Rezan Topaloglu

  20. IPNA–ESPN Junior Master Class—a decade of successful continuing education and training in pediatric nephrology

    Article • Pediatric Nephrology, April 2023, Springer Science + Business Media

    Dr. Rezan Topaloglu

  21. Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study

    Article • Journal of Inherited Metabolic Disease, October 2022, Wiley

    Dr. Rezan Topaloglu

  22. Response to Dr. Spizzirri et al

    Article • Pediatric Nephrology, August 2022, Springer Science + Business Media

    Dr. Rezan Topaloglu

  23. Urinary HSP70 improves diagnostic accuracy for urinary tract infection in children: UTILISE study

    Article • Pediatric Nephrology, July 2022, Springer Science + Business Media

    Dr. Rezan Topaloglu

  24. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy

    Article • Kidney International, July 2022, Elsevier

    Dr. Rezan Topaloglu

  25. Improved Outcome of Infantile Oxalosis Over Time in Europe: Data From the OxalEurope Registry

    Article • Kidney International Reports, July 2022, Elsevier

    Dr. Rezan Topaloglu

  26. A rare cause of nephrotic syndrome—sphingosine-1-phosphate lyase (SGPL1) deficiency: 6 cases and a review of the literature

    Article • Pediatric Nephrology, June 2022, Springer Science + Business Media

    Dr. Rezan Topaloglu

  27. Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin

    Article • Science, June 2022, American Association for the Advancement of Science

    Dr. Rezan Topaloglu

  28. Predictors of kidney complications and analysis of hypertension in children with allogeneic hematopoietic stem cell transplantation

    Article • Pediatric Nephrology, May 2022, Springer Science + Business Media

    Dr. Rezan Topaloglu

  29. Young Adults With Hereditary Tubular Diseases: Practical Aspects for Adult-Focused Colleagues

    Article • Advances in Chronic Kidney Disease, May 2022, Elsevier

    Professor Guido Filler, Dr. Rezan Topaloglu

  30. Managing the Nutritional Requirements of the Pediatric End-Stage Kidney Disease Graduate

    Article • Advances in Chronic Kidney Disease, May 2022, Elsevier

    Dr. Rezan Topaloglu

  31. Correction to: Cystinosis beyond kidneys: gastrointestinal system and muscle involvement

    Article • BMC Gastroenterology, April 2022, Springer Science + Business Media

    Dr. Rezan Topaloglu

  32. Mitochondria-targeted CoQ10 loaded PLGA-b-PEG-TPP nanoparticles: Their effects on mitochondrial functions of COQ8B HK-2 cells

    Article • European Journal of Pharmaceutics and Biopharmaceutics, April 2022, Elsevier

    Dr. Rezan Topaloglu

  33. Hospitalization following pediatric kidney transplantation: An international comparison among a Canadian pediatric transplant center, North American Pediatric Renal Trials and Collaborative Studies, and Cooperative European Pediatric Renal Transplant I...

    Article • Pediatric Transplantation, March 2022, Wiley

    Dr. Rezan Topaloglu

  34. Newborn Screening: Review of its Impact for Cystinosis

    Article • Cells, March 2022, MDPI AG

    Dr. Rezan Topaloglu

  35. Glomerulonephritis with crescents in childhood; etiologies and significance of M2 macrophages

    Article • The Turkish Journal of Pediatrics, February 2022, The Turkish Journal of Pediatrics

    Dr. Rezan Topaloglu

  36. Correction to: Impact of coronavirus disease-2019 on pediatric nephrology practice and education: an ESPN survey

    Article • Pediatric Nephrology, February 2022, Springer Science + Business Media

    Professor Rajendra Bhimma, Dr. Rezan Topaloglu

  37. Blood filters in children with COVID‐19 and acute kidney injury: A review

    Article • Therapeutic Apheresis and Dialysis, January 2022, Wiley

    Dr. Rezan Topaloglu

  38. A broad clinical spectrum of PLCε1-related kidney disease and intrafamilial variability

    Article • Pediatric Nephrology, January 2022, Springer Science + Business Media

    Dr. Rezan Topaloglu

  39. Mitigation of portal fibrosis and cholestatic liver disease in ANKS6 ‐deficient livers by macrophage depletion

    Article • The FASEB Journal, January 2022, Wiley

    Dr. Rezan Topaloglu

  40. A splice site mutation in the TSEN2 causes a new syndrome with craniofacial and central nervous system malformations, and atypical hemolytic uremic syndrome

    Article • Clinical Genetics, January 2022, Wiley

    Dr. Rezan Topaloglu

  41. Impact of coronavirus disease-2019 on pediatric nephrology practice and education: an ESPN survey

    Article • Pediatric Nephrology, December 2021, Springer Science + Business Media

    Professor Rajendra Bhimma, Prof Dmytro D Ivanov, Dr. Rezan Topaloglu

  42. Could plasma based therapies still be considered in selected cases with atypical hemolytic uremic syndrome?

    Article • The Turkish Journal of Pediatrics, December 2021, The Turkish Journal of Pediatrics

    Dr. Rezan Topaloglu

  43. Deubiquitination of proteasome subunits by OTULIN regulates type I IFN production

    Article • Science Advances, November 2021, American Association for the Advancement of Science

    Dr. Rezan Topaloglu

  44. An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis

    Article • Kidney International, November 2021, Elsevier

    Dr. Rezan Topaloglu

  45. Diversity in Serine/Threonine Protein Kinase-4 Deficiency and Review of the Literature

    Article • The Journal of Allergy and Clinical Immunology In Practice, October 2021, Elsevier

    Dr. Rezan Topaloglu

  46. Acute kidney injury in a patient with COVID-19: Answers

    Article • Pediatric Nephrology, September 2021, Springer Science + Business Media

    Dr. Rezan Topaloglu

  47. Acute kidney injury in a patient with COVID-19: Questions

    Article • Pediatric Nephrology, September 2021, Springer Science + Business Media

    Dr. Rezan Topaloglu

  48. Updating the International IgA Nephropathy Prediction Tool for use in children

    Article • Kidney International, June 2021, Elsevier

    Dr. Rezan Topaloglu

  49. Long-term renal survival of paediatric patients with lupus nephritis

    Article • Nephrology Dialysis Transplantation, May 2021, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  50. Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?

    Article • Pediatric Nephrology, May 2021, Springer Science + Business Media

    Dr. Rezan Topaloglu

  51. Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy

    Article • Kidney International, May 2021, Elsevier

    Nicholas Chesnaye, Dr. Rezan Topaloglu

  52. Aetiology, course and treatment of acute tubulointerstitial nephritis in paediatric patients: a cross-sectional web-based survey

    Article • BMJ Open, May 2021, BMJ

    Dr. Rezan Topaloglu

  53. Distal renal tubular acidosis: ERKNet/ESPN clinical practice points

    Article • Nephrology Dialysis Transplantation, April 2021, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  54. Plasma checkpoint protein levels and galectin-9 in juvenile systemic lupus erythematosus

    Article • Lupus, March 2021, SAGE Publications

    Dr. Rezan Topaloglu

  55. Clinical practice recommendations for recurrence of focal and segmental glomerulosclerosis/steroid‐resistant nephrotic syndrome

    Article • Pediatric Transplantation, December 2020, Wiley

    Dr. Rezan Topaloglu

  56. Determinants of outcomes in chronic pediatric peritoneal dialysis: a single center experience

    Article • The Turkish Journal of Pediatrics, December 2020, The Turkish Journal of Pediatrics

    Dr. Rezan Topaloglu

  57. Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy

    Article • Journal of the American Society of Nephrology, December 2020, American Society of Nephrology

    Sean Barbour, Dr. Rezan Topaloglu

  58. Promoting Breastfeeding and Interaction of Pediatric Associations With Providers of Nutritional Products

    Article • Frontiers in Pediatrics, November 2020, Frontiers

    Dr. Rezan Topaloglu

  59. Transplantation in pediatric aHUS within the era of eculizumab therapy

    Article • Pediatric Transplantation, November 2020, Wiley

    Dr. Rezan Topaloglu

  60. Clinical characteristics of children with congenital anomalies of the kidney and urinary tract and predictive factors of chronic kidney disease

    Article • The Turkish Journal of Pediatrics, October 2020, The Turkish Journal of Pediatrics

    Dr. Rezan Topaloglu

  61. Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool

    Article • Kidney International, October 2020, Elsevier

    Dr. Rezan Topaloglu

  62. Predictors for the use of herbal and dietary supplements in children and adolescents with kidney and urinary tract diseases

    Article • European Journal of Pediatrics, August 2020, Springer Science + Business Media

    Dr. Rezan Topaloglu

  63. Cystinosis beyond kidneys: gastrointestinal system and muscle involvement

    Article • BMC Gastroenterology, July 2020, Springer Science + Business Media

    Dr. Rezan Topaloglu

  64. Nephropathic cystinosis: an update on genetic conditioning

    Article • Pediatric Nephrology, June 2020, Springer Science + Business Media

    Dr. Rezan Topaloglu

  65. COL4A3 mutation is an independent risk factor for poor prognosis in children with Alport syndrome

    Article • Pediatric Nephrology, May 2020, Springer Science + Business Media

    Dr. Rezan Topaloglu

  66. Whole exome sequencing identified ATP6V1C2 as a novel candidate gene for recessive distal renal tubular acidosis

    Article • Kidney International, March 2020, Elsevier

    Dr. Rezan Topaloglu

  67. Growth Patterns After Kidney Transplantation in European Children Over the Past 25 Years: An ESPN/ERA-EDTA Registry Study

    Article • Transplantation, January 2020, Wolters Kluwer Health

    Dr. Rezan Topaloglu

  68. Sex and age as determinants for high blood pressure in pediatric renal transplant recipients: a longitudinal analysis of the CERTAIN Registry

    Article • Pediatric Nephrology, December 2019, Springer Science + Business Media

    Dr. Rezan Topaloglu

  69. A rare cause of steroid resistant nephrotic syndrome in a child: Questions

    Article • Pediatric Nephrology, December 2019, Springer Science + Business Media

    Dr. Rezan Topaloglu

  70. A rare cause of steroid-resistant nephrotic syndrome in a child: Answers

    Article • Pediatric Nephrology, December 2019, Springer Science + Business Media

    Dr. Rezan Topaloglu

  71. CD80 expression and infiltrating regulatory T cells in idiopathic nephrotic syndrome of childhood

    Article • Pediatrics International, December 2019, Wiley

    Dr. Rezan Topaloglu

  72. The European Society for Paediatric Nephrology study of pediatric renal care in Europe: comparative analysis 1998–2017

    Article • Pediatric Nephrology, October 2019, Springer Science + Business Media

    Prof Dmytro D Ivanov, Dr. Rezan Topaloglu

  73. Long-term follow-up results of patients with ADCK4 mutations who have been diagnosed in the asymptomatic period: effects of early initiation of CoQ10 supplementation

    Article • The Turkish Journal of Pediatrics, October 2019, The Turkish Journal of Pediatrics

    Dr. Rezan Topaloglu

  74. Management of bone disease in cystinosis: Statement from an international conference

    Article • Journal of Inherited Metabolic Disease, August 2019, Wiley

    Dr. Rezan Topaloglu

  75. Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth

    Article • Frontiers in Pediatrics, July 2019, Frontiers

    Dr. Rezan Topaloglu

  76. Psychiatric morbidity and different treatment modalities in children with chronic kidney disease

    Article • Archives de Pédiatrie, July 2019, Elsevier

    Dr. Rezan Topaloglu

  77. Surgical management of renovascular hypertension in children and young adults: a 13-year experience

    Article • Interactive Cardiovascular and Thoracic Surgery, June 2019, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  78. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study

    Article • Transplantation, June 2019, Wolters Kluwer Health

    Dr. Rezan Topaloglu

  79. Erratum to ‘Response to early coenzyme Q10 supplementation is not sustained in CoQ10 deficiency caused by CoQ2 mutation’ [Pediatric Neurology 88 (2018) 71–74]

    Article • Pediatric Neurology, May 2019, Elsevier

    Dr. Rezan Topaloglu

  80. BK virus associated nephropathy and severe pneumonia in a kidney transplanted adolescent with Schimke immuneosseous- dysplasia

    Article • The Turkish Journal of Pediatrics, February 2019, The Turkish Journal of Pediatrics

    Dr. Rezan Topaloglu

  81. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis

    Article • Pediatric Nephrology, January 2019, Springer Science + Business Media

    Professor Ozgur KASAPCOPUR, Dr. Rezan Topaloglu

  82. Do not Miss Rare and Treatable Cause of Early-Onset Hemolytic Uremic Syndrome: Cobalamin C Deficiency

    Article • Nephron, January 2019, Karger Publishers

    Dr. Rezan Topaloglu

  83. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort

    Article • Nephrology Dialysis Transplantation, December 2018, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  84. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update

    Article • Nephrology Dialysis Transplantation, November 2018, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  85. Response to Early Coenzyme Q10 Supplementation Is not Sustained in CoQ10 Deficiency Caused by CoQ2 Mutation

    Article • Pediatric Neurology, November 2018, Elsevier

    Dr. Rezan Topaloglu

  86. Risk Factors for Early Dialysis Dependency in Autosomal Recessive Polycystic Kidney Disease

    Article • The Journal of Pediatrics, August 2018, Elsevier

    Dr. Rezan Topaloglu

  87. JC polyomavirus replication and associated disease in pediatric renal transplantation: an international CERTAIN Registry study

    Article • Pediatric Nephrology, July 2018, Springer Science + Business Media

    Dr. Rezan Topaloglu

  88. Outcome of renal transplantation in small infants: a match-controlled analysis

    Article • Pediatric Nephrology, March 2018, Springer Science + Business Media

    Dr. Rezan Topaloglu

  89. Hypomorphic RAG1 defect in a child presented with pulmonary hemorrhage and digital necrosis

    Article • Clinical Immunology, February 2018, Elsevier

    Dr. Rezan Topaloglu

  90. Incomplete vaccination coverage in European children with end-stage kidney disease prior to renal transplantation

    Article • Pediatric Nephrology, October 2017, Springer Science + Business Media

    Dr. Rezan Topaloglu

  91. Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly

    Article • Nature Genetics, August 2017, Springer Science + Business Media

    Dr. Rezan Topaloglu

  92. The Clinical and Mutational Spectrum of Turkish Patients with Cystinosis

    Article • Clinical Journal of the American Society of Nephrology, August 2017, American Society of Nephrology

    Dr. Rezan Topaloglu

  93. Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis

    Article • American Journal of Kidney Diseases, May 2017, Elsevier

    Nicholas Chesnaye, Prof Dmytro D Ivanov, Dr. Rezan Topaloglu

  94. Dyslipidemia after pediatric renal transplantation-The impact of immunosuppressive regimens

    Article • Pediatric Transplantation, March 2017, Wiley

    Dr. Rezan Topaloglu

  95. Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment

    Article • Pediatric Nephrology, March 2017, Springer Science + Business Media

    Dr. Rezan Topaloglu

  96. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis

    Article • The Turkish Journal of Pediatrics, February 2017, The Turkish Journal of Pediatrics

    Dr. Rezan Topaloglu

  97. Kidney Versus Combined Kidney and Liver Transplantation in Young People With Autosomal Recessive Polycystic Kidney Disease: Data From the European Society for Pediatric Nephrology/European Renal Association−European Dialysis and Transplant (ESPN/ERA-ED...

    Article • American Journal of Kidney Diseases, November 2016, Elsevier

    Prof Dmytro D Ivanov, Dr. Rezan Topaloglu

  98. Timing of renal replacement therapy does not influence survival and growth in children with congenital nephrotic syndrome caused by mutations in NPHS1: data from the ESPN/ERA-EDTA Registry

    Article • Pediatric Nephrology, October 2016, Springer Science + Business Media

    Dr. Rezan Topaloglu

  99. Erratum to: Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort

    Article • Pediatric Nephrology, October 2016, Springer Science + Business Media

    Dr. Rezan Topaloglu

  100. Traitement par étanercept de cinq cas d’ostéomyélite multifocale chronique récurrente (OMCR) réfractaires

    Article • Revue du Rhumatisme, October 2016, Elsevier

    Dr. Rezan Topaloglu

  101. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort

    Article • Pediatric Nephrology, August 2016, Springer Science + Business Media

    Dr. Rezan Topaloglu

  102. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease

    Article • Proceedings of the National Academy of Sciences, August 2016, Proceedings of the National Academy of Sciences

    Dr. Rezan Topaloglu

  103. Familial Mediterranean fever patients homozygous for E148Q variant may have milder disease

    Article • International Journal of Rheumatic Diseases, July 2016, Wiley

    Dr. Rezan Topaloglu

  104. Gender Disparities in Access to Pediatric Renal Transplantation in Europe: Data From the ESPN/ERA‐EDTA Registry

    Article • Arabian archaeology and epigraphy, July 2016, Elsevier

    Prof Dmytro D Ivanov, Dr. Rezan Topaloglu

  105. Controversies and research agenda in nephropathic cystinosis: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Article • Kidney International, June 2016, Elsevier

    Professor Neveen A Soliman, Dr. Rezan Topaloglu

  106. Cytomegalovirus Infection in Pediatric Renal Transplantation and the Impact of Chemoprophylaxis With (Val-)Ganciclovir

    Article • Transplantation, April 2016, Wolters Kluwer Health

    Dr. Rezan Topaloglu

  107. Impact of Everolimus and Low-Dose Cyclosporin on Cytomegalovirus Replication and Disease in Pediatric Renal Transplantation

    Article • Arabian archaeology and epigraphy, March 2016, Elsevier

    Dr. Rezan Topaloglu

  108. The MEST score provides earlier risk prediction in lgA nephropathy

    Article • Kidney International, January 2016, Elsevier

    Dr. Rezan Topaloglu

  109. Etanercept treatment in five cases of refractory chronic recurrent multifocal osteomyelitis (CRMO)

    Article • Joint Bone Spine, December 2015, Elsevier

    Dr. Rezan Topaloglu

  110. Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases

    Article • Pediatric Nephrology, November 2015, Springer Science + Business Media

    Dr. Rezan Topaloglu

  111. Marked variability in clinical presentation and outcome of patients with C1q immunodeficiency

    Article • Journal of Autoimmunity, August 2015, Elsevier

    Dr. Rezan Topaloglu

  112. Lupus in a patient with cystinosis: is it drug induced?

    Article • Lupus, July 2015, SAGE Publications

    Dr. Rezan Topaloglu

  113. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents

    Article • Rheumatology International, May 2015, Springer Science + Business Media

    Dr. Rezan Topaloglu

  114. Renal transplantation experience in a patient with factor V Leiden homozygous, MTHFR C677T heterozygous, and PAI heterozygous mutation

    Article • Pediatric Transplantation, May 2015, Wiley

    Dr. Rezan Topaloglu

  115. Does Lower Urinary Tract Status Affect Renal Transplantation Outcomes in Children?

    Article • Transplantation Proceedings, May 2015, Elsevier

    Dr. Rezan Topaloglu

  116. Disparities in treatment rates of paediatric end-stage renal disease across Europe: insights from the ESPN/ERA-EDTA registry

    Article • Nephrology Dialysis Transplantation, April 2015, Oxford University Press (OUP)

    Nicholas Chesnaye, Dr. Rezan Topaloglu

  117. Bisphosphonates in juvenile dermatomyositis with dystrophic calcinosis

    Article • Modern Rheumatology, March 2015, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  118. Genetic abnormalities and prognosis in patients with congenital and infantile nephrotic syndrome

    Article • Pediatric Nephrology, February 2015, Springer Science + Business Media

    Dr. Rezan Topaloglu

  119. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

    Article • Kidney International, October 2014, Elsevier

    Dr. Rezan Topaloglu

  120. Nephropathic cystinosis: an international consensus document

    Article • Nephrology Dialysis Transplantation, August 2014, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  121. Mutations in ANKS6 Cause a Nephronophthisis-Like Phenotype with ESRD

    Article • Journal of the American Society of Nephrology, August 2014, Wolters Kluwer Health

    Dr. Rezan Topaloglu

  122. Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA–EDTA registry

    Article • Pediatric Nephrology, July 2014, Springer Science + Business Media

    Nicholas Chesnaye, Dr. Rezan Topaloglu

  123. Case series of thromboembolic complications in childhood nephrotic syndrome: Hacettepe experience

    Article • Clinical and Experimental Nephrology, July 2014, Springer Science + Business Media

    Dr. Rezan Topaloglu

  124. Wegener’s Granulomatosis Presenting With an Isolated Paranasal Sinus Involvement in a Child

    Article • Archives of Rheumatology, June 2014, The Archives of Rheumatology

    Dr. Rezan Topaloglu

  125. Post-transplant hypertension in pediatric kidney transplant recipients

    Article • Pediatric Nephrology, January 2014, Springer Science + Business Media

    Dr. Rezan Topaloglu

  126. Disparities in Policies, Practices and Rates of Pediatric Kidney Transplantation in Europe

    Article • Arabian archaeology and epigraphy, August 2013, Elsevier

    Dr. Rezan Topaloglu

  127. QT and JT dispersion and cardiac performance in children with neonatal Bartter syndrome: a pilot study

    Article • Pediatric Nephrology, June 2013, Springer Science + Business Media

    Dr. Rezan Topaloglu

  128. The CERTAIN Registry: A Novel, Web-Based Registry and Research Platform for Pediatric Renal Transplantation in Europe

    Article • Transplantation Proceedings, May 2013, Elsevier

    Dr. Rezan Topaloglu

  129. DGKE Variants Cause a Glomerular Microangiopathy That Mimics Membranoproliferative GN

    Article • Journal of the American Society of Nephrology, March 2013, Wolters Kluwer Health

    Dr. Rezan Topaloglu

  130. Clinicopathological and immunohistological features in childhood IgA nephropathy: a single-centre experience

    Article • Clinical Kidney Journal, February 2013, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  131. Molecular characterization of cystinuria in south-eastern European countries

    Article • Urolithiasis, December 2012, Springer Science + Business Media

    Prof Dijana Plaseska-Karanfilska, Dr. Rezan Topaloglu

  132. Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab

    Article • Pediatric Nephrology, September 2012, Springer Science + Business Media

    Dr. Rezan Topaloglu

  133. C1q deficiency: identification of a novel missense mutation and treatment with fresh frozen plasma

    Article • Clinical Rheumatology, May 2012, Springer Science + Business Media

    Dr. Rezan Topaloglu

  134. Genetic basis of cystinosis in Turkish patients: a single-center experience

    Article • Pediatric Nephrology, July 2011, Springer Science + Business Media

    Dr. Rezan Topaloglu

  135. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness

    Article • Journal of Clinical Investigation, May 2011, American Society for Clinical Investigation

    Dr Carlos Santos Ocaña, Professor Neveen A Soliman, Dr. Rezan Topaloglu

  136. Follow-Up of Patients With Juvenile Nephronophthisis After Renal Transplantation: A Single Center Experience

    Article • Transplantation Proceedings, April 2011, Elsevier

    Dr. Rezan Topaloglu

  137. Hereditary renal tubular disorders in Turkey: demographic, clinical, and laboratory features

    Article • Clinical and Experimental Nephrology, November 2010, Springer Science + Business Media

    Dr. Rezan Topaloglu

  138. Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children

    Article • Pediatric Nephrology, February 2010, Springer Science + Business Media

    Dr. Rezan Topaloglu

  139. Low cortisol levels in active juvenile idiopathic arthritis

    Article • Clinical Rheumatology, December 2009, Springer Science + Business Media

    Dr. Rezan Topaloglu

  140. Increased frequency of extremely skewed X chromosome inactivation in juvenile idiopathic arthritis

    Article • Arthritis & Rheumatism, November 2009, Wiley

    Professor Ozgur KASAPCOPUR, Dr. Rezan Topaloglu

  141. Chronic kidney disease in children in Turkey

    Article • Pediatric Nephrology, April 2009, Springer Science + Business Media

    Dr. Rezan Topaloglu

  142. Erratum to: Chronic kidney disease in children in Turkey

    Article • Pediatric Nephrology, April 2009, Springer Science + Business Media

    Dr. Rezan Topaloglu

  143. MEFV mutations in systemic onset juvenile idiopathic arthritis

    Article • Rheumatology, November 2008, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  144. Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up

    Article • Clinical Rheumatology, May 2008, Springer Science + Business Media

    Dr. Rezan Topaloglu

  145. Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis

    Article • Rheumatology International, May 2008, Springer Science + Business Media

    Dr. Rezan Topaloglu

  146. Henoch–Schonlein purpura with high factor VIII levels and deep venous thrombosis: an association or coincidence?

    Article • Rheumatology International, February 2008, Springer Science + Business Media

    Dr. Rezan Topaloglu

  147. Outcome of Primary Glomerular Disease in Pediatric Renal Transplantation: A Single-Center Experience

    Article • Transplantation Proceedings, January 2008, Elsevier

    Dr. Rezan Topaloglu

  148. Renal Transplantation in Children With Lower Urinary Tract Dysfunction of Different Origin: A Single-Center Experience

    Article • Transplantation Proceedings, January 2008, Elsevier

    Dr. Rezan Topaloglu

  149. Triple Immunosuppression With Tacrolimus in Pediatric Renal Transplantation: Single-Center Experience

    Article • Transplantation Proceedings, January 2008, Elsevier

    Dr. Rezan Topaloglu

  150. Eye involvement in children with primary focal segmental glomerulosclerosis

    Article • Pediatric Nephrology, December 2007, Springer Science + Business Media

    Dr. Rezan Topaloglu

  151. Effect of carnitine supplementation on cardiac function in hemodialyzed children

    Article • Pediatrics International, October 2007, Wiley

    Dr. Rezan Topaloglu

  152. Carotid intima–media thickness in children and young adults with renal transplant: Internal carotid artery vs. common carotid artery

    Article • Pediatric Transplantation, June 2007, Wiley

    Dr. Rezan Topaloglu

  153. Acute Tubular Injury Associated with Mesalazine Therapy in an Adolescent Girl with Inflammatory Bowel Disease

    Article • Digestive Diseases and Sciences, April 2007, Springer Science + Business Media

    Dr. Rezan Topaloglu

  154. Is the CD14 C159T polymorphism effective in the development of secondary amyloidosis in Familial Mediterranean fever?

    Article • Rheumatology International, December 2006, Springer Science + Business Media

    Dr. Rezan Topaloglu

  155. A patient with hyper-IgD syndrome responding to anti-TNF treatment

    Article • Clinical Rheumatology, December 2006, Springer Science + Business Media

    Dr. Rezan Topaloglu

  156. Cyclosporine drug monitoring with C0 and C2 concentrations in children with stable renal allograft function

    Article • Pediatric Transplantation, March 2006, Wiley

    Dr. Rezan Topaloglu

  157. A multicenter study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritis

    Article • Clinical Rheumatology, December 2005, Springer Science + Business Media

    Dr. Rezan Topaloglu

  158. Apoptosis and proliferation in childhood acute proliferative glomerulonephritis

    Article • Pediatric Nephrology, June 2005, Springer Science + Business Media

    Dr. Rezan Topaloglu

  159. E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean fever

    Article • Annals of the Rheumatic Diseases, May 2005, Elsevier

    Dr. Rezan Topaloglu

  160. An unusual presentation of classic polyarteritis nodosa in a child

    Article • Pediatric Nephrology, April 2005, Springer Science + Business Media

    Dr. Rezan Topaloglu

  161. Familial Mediterranean Fever (FMF) in Turkey

    Article • Medicine, January 2005, Wolters Kluwer Health

    Professor Ozgur KASAPCOPUR, Professor Merih Birlik, Dr. Rezan Topaloglu

  162. The significance of IgA class of antineutrophil cytoplasmic antibodies (ANCA) in childhood Henoch?Sch�nlein purpura

    Article • Clinical Rheumatology, June 2004, Springer Science + Business Media

    Dr. Rezan Topaloglu

  163. Monocyte chemoattractant protein-1 and interleukin-8 levels in children with acute poststreptococcal glomerulonephritis

    Article • Pediatric Nephrology, June 2004, Springer Science + Business Media

    Dr. Rezan Topaloglu

  164. Bone mineral density in children with familial Mediterranean fever

    Article • Clinical Rheumatology, June 2004, Springer Science + Business Media

    Dr. Rezan Topaloglu

  165. Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis

    Article • Genes & Immunity, April 2004, Nature

    Professor Michael McDermott, Dr. Rezan Topaloglu

  166. Helicobacter pylori infection in Turkish children with familial Mediterranean fever: is it a cause of persistent inflammation?

    Article • Clinical Rheumatology, April 2004, Springer Science + Business Media

    Dr. Rezan Topaloglu

  167. An unusual pattern of arthritis in a child with Kawasaki syndrome

    Article • Clinical Rheumatology, January 2004, Springer Science + Business Media

    Dr. Rezan Topaloglu

  168. Silence on clinical fundamentals

    Article • British Journal of Sports Medicine, December 2003, BMJ

    Dr. Rezan Topaloglu

  169. Mutational analysis of the xanthine dehydrogenase gene in a Turkish family with autosomal recessive classical xanthinuria

    Article • Nephrology Dialysis Transplantation, November 2003, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  170. Low serum apolipoprotein AI levels in amyloidosis related to familial Mediterranean fever

    Article • Pediatric Nephrology, October 2003, Springer Science + Business Media

    Dr. Rezan Topaloglu

  171. The role of apoptosis in childhood Henoch?Schonlein purpura

    Article • Clinical Rheumatology, October 2003, Springer Science + Business Media

    Dr. Rezan Topaloglu

  172. Questions

    Article • Pediatric Nephrology, September 2003, Springer Science + Business Media

    Dr. Rezan Topaloglu

  173. Urinary glycosaminoglycans in the course of familial Mediterranean fever

    Article • European Journal of Pediatrics, March 2003, Springer Science + Business Media

    Dr. Rezan Topaloglu

  174. A phenocopy of CAII deficiency: a novel genetic explanation for inherited infantile osteopetrosis with distal renal tubular acidosis

    Article • Journal of Medical Genetics, February 2003, BMJ

    Dr. Rezan Topaloglu

  175. Confirmation of the ATP6B1 gene as responsible for distal renal tubular acidosis

    Article • Pediatric Nephrology, December 2002, Springer Science + Business Media

    Professor Christopher Rensing, Professor Guido Filler, Dr. Rezan Topaloglu

  176. MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: a retrospective clinicopathological and molecular study

    Article • Nephrology Dialysis Transplantation, November 2002, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  177. Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss

    Article • Journal of Medical Genetics, November 2002, BMJ

    Dr. Rezan Topaloglu

  178. Reduced Tc-99m DMSA uptake in a patient with renal tubular acidosis: Effect of acid-base imbalance

    Article • Annals of Nuclear Medicine, November 2002, Springer Science + Business Media

    Dr. Rezan Topaloglu

  179. Ataxia and peripheral neuropathy: rare manifestations in Henoch-Schönlein purpura

    Article • Pediatric Nephrology, December 2001, Springer Science + Business Media

    Dr. Rezan Topaloglu

  180. Pediatric renal transplantation: experience from a center in central Anatolia

    Article • Transplantation Proceedings, November 2001, Elsevier

    Dr. Rezan Topaloglu

  181. Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population

    Article • European Journal of Human Genetics, July 2001, Springer Science + Business Media

    Dr. Rezan Topaloglu

  182. Pulmonary Haemorrhage in a 6-Year-Old Boy with Henoch–Scho¨nlein Purpura

    Article • Clinical Rheumatology, July 2001, Springer Science + Business Media

    Dr. Rezan Topaloglu

  183. Survey of Factor V Leiden and Prothrombin Gene Mutations in Systemic Lupus Erythematosus

    Article • Clinical Rheumatology, July 2001, Springer Science + Business Media

    Dr. Rezan Topaloglu

  184. Henoch-Schönlein purpura in Wiskott-Aldrich syndrome

    Article • Pediatric Nephrology, May 2001, Springer Science + Business Media

    Dr. Rezan Topaloglu

  185. Low Chloride Stimulation of Prostaglandin E2Release and Cyclooxygenase-2 Expression in a Mouse Macula Densa Cell Line

    Article • Journal of Biological Chemistry, December 2000, Elsevier

    Dr. Rezan Topaloglu

  186. A novel G472R mutation in a Turkish family with X-linked Alport syndrome

    Article • Pediatric Nephrology, May 2000, Springer Science + Business Media

    Dr. Rezan Topaloglu

  187. Renal involvement in polyarteritis nodosa: evaluation of 26 Turkish children

    Article • Pediatric Nephrology, March 2000, Springer Science + Business Media

    Dr. Rezan Topaloglu

  188. Langerhans' Cell Histiocytosis: Report of an Atypical Case

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2000, De Gruyter

    Dr. Rezan Topaloglu

  189. Antineutrophil Cytoplasmic Antibodies in Juvenile Chronic Arthritis

    Article • Clinical Rheumatology, June 1999, Springer Science + Business Media

    Dr. Rezan Topaloglu

  190. Evaluation of tumour necrosis factor alpha, interferon gamma and granulocyte-macrophage colony stimulating factor levels in juvenile chronic arthritis.

    Article • Rheumatology, May 1999, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  191. Wilms' tumour-associated late nephrotic syndrome responsive to treatment

    Article • Nephrology Dialysis Transplantation, April 1999, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  192. Renovascular hypertension and prolonged encephalopathy associated with moyamoya disease

    Article • European Journal of Pediatrics, March 1999, Springer Science + Business Media

    Dr. Rezan Topaloglu

  193. Kindler syndrome: Absence of definite ultrastructural feature

    Article • Journal of the American Academy of Dermatology, February 1999, Elsevier

    Dr. Rezan Topaloglu

  194. Nutritional assessment of children on haemodialysis: value of IGF-I, TNF-&agr; and IL-1beta

    Article • Nephrology Dialysis Transplantation, June 1998, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  195. Antineutrophil cytoplasmic antibodies in childhood systemic lupus erythematosus

    Article • Clinical Rheumatology, May 1998, Springer Science + Business Media

    Dr. Rezan Topaloglu

  196. Two novel mutations of the gene for Kir 1.1 (ROMK) in neonatal Bartter syndrome

    Article • Pediatric Nephrology, January 1998, Springer Science + Business Media

    Dr. Rezan Topaloglu

  197. A candidate gene for familial Mediterranean fever

    Article • Nature Genetics, September 1997, Springer Science + Business Media

    Dr. Rezan Topaloglu

  198. Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis

    Article • European Journal of Pediatrics, July 1997, Springer Science + Business Media

    Dr. Rezan Topaloglu

  199. A rare cause of acute tubulointerstitial nephritis: Salmonella typhimurium infection

    Article • Nephrology Dialysis Transplantation, July 1997, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  200. Molecular basis of hereditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish family

    Article • Kidney International, August 1996, Elsevier

    Dr. Rezan Topaloglu

  201. Plasma lipids and lipoproteins in juvenile chronic arthritis

    Article • Clinical Rheumatology, July 1996, Springer Science + Business Media

    Dr. Rezan Topaloglu

  202. Comparison of Ceftriaxone versus Cefotaxime for Childhood Upper Urinary Tract Infections

    Article • Journal of Chemotherapy, January 1996, Taylor & Francis

    Professor Ali Osman Saatci, Dr. Rezan Topaloglu

  203. T-cell subsets, interleukin-2 receptor expression and production of interleukin-2 in minimal change nephrotic syndrome

    Article • Pediatric Nephrology, December 1994, Springer Science + Business Media

    Dr. Rezan Topaloglu

  204. Brown tumour as a complication of secondary hyperparathyroidism in uraemia: A case report

    Article • International Urology and Nephrology, September 1994, Springer Science + Business Media

    Dr. Rezan Topaloglu

  205. Muscle Ultrasound Evaluation of Patients with Familial Mediterranean Fever Complicated by Myalgia

    Article • Rheumatology, January 1994, Oxford University Press (OUP)

    Dr. Rezan Topaloglu

  206. Cranial nerve involvement in childhood polyarteritis nodosa

    Article • Clinical Neurology and Neurosurgery, May 1992, Elsevier

    Dr. Rezan Topaloglu

  207. Long-Term Follow-Up in Children with Steroid-Resistant Nephrotic Syndrome

    Article • Clinical Pediatrics, May 1992, SAGE Publications

    Dr. Rezan Topaloglu

  208. Peritoneal Hemosiderosis in Pediatric Patients with Nephrogenic Ascites

    Article • Nephron, January 1992, Karger Publishers

    Dr. Rezan Topaloglu

  209. Protein C and anti-thrombin III levels in nephrotic syndrome and amyloidosis

    Article • Pediatric Nephrology, January 1992, Springer Science + Business Media

    Dr. Rezan Topaloglu

  210. Hyperimmunoglobulinaemia D and periodic fever mimicking familial Mediterranean fever in the Mediterranean.

    Article • Postgraduate Medical Journal, May 1991, BMJ

    Professor Ali Osman Saatci, Dr. Rezan Topaloglu

  211. Early onset of stone diseases and primary hyperoxaluria

    Article • International Urology and Nephrology, May 1990, Springer Science + Business Media

    Dr. Rezan Topaloglu

  212. Carbamazepine induced systemic lupus erythematosus

    Article • Clinical Neurology and Neurosurgery, January 1990, Elsevier

    Dr. Rezan Topaloglu

  213. Turkish Journal of Hematology

    Article • Turkish Journal of Hematology, Journal of Clinical Research of Pediatric Endocrinology

    Dr. Rezan Topaloglu